Batches of the world’s first vaccine against the hepatitis E virus began rolling out of a Chinese factory, promising to stem a disease that every year infects about 20 million people and claims 70,000 lives. The vaccine is being hailed as a victory for an unusual public–private partnership that could set a precedent in China’s burgeoning biotechnology sector, and help to deliver other vaccines for diseases overlooked in the West.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/hepatitis-e-vaccine-debuts
[2] http://admin.indiaenvironmentportal.org.in/category/author/soo-bin-park
[3] http://admin.indiaenvironmentportal.org.in/category/journal/nature
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/hepatitis
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/china
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/public-sector
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/private-sector
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/biotechnology-industry
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/waterborne-diseases
